Steven Smith, Pharm.D., M.P.H., has been invited by the National Academies of Sciences, Engineering, and Medicine to serve on the consensus study Committee on Clinical Preventive Services for Addressing Cardiovascular Disease Risk to Reduce Pregnancy-related Deaths Among Women.
As an associate professor and chair of the Department of Pharmaceutical Outcomes and Policy in the University of Florida College of Pharmacy, Smith’s research focuses on optimizing medication use for cardiovascular disease prevention and treatment at the population level. He is an elected fellow of the American Heart Association and the American College of Clinical Pharmacy and a member of the Centers for Disease Control and Prevention National Hypertension Control Roundtable.
The committee will review what clinical services are necessary for preventing cardiovascular conditions among women to reduce pregnancy-related morbidity and mortality. In conducting this work, the committee will identify gaps in recommended services and screenings for women, including interventions identified as effective in recent research. Committee members will also identify promising research to close the identified evidence gaps in recommended services and screenings for cardiovascular disease among women.
Smith’s appointment begins immediately and will end with the publication of the consensus study in early 2026.